Email Updates

Search form

You are here

Browse and Order Resources

Research & Reality calls on funders and researchers to capitalize on lessons learned from a range of recent HIV prevention trials via better problem solving, more critical thinking and coordinated action. This year's AVAC Report identifies progress and gaps in large-scale human trials, rollout of proven options and ongoing research for new advances that women and men will want to use. (View on the web here.)

December, 2013
AVAC
AVAC Report

AVAC Report 2012, Achieving the End—One Year and Counting, sets a clock on the global drive to end the AIDS epidemic. The past twelve months have seen remarkable global consensus that it is possible to begin to end the epidemic. The same time period has seen concepts like “combination prevention” and “treatment as prevention” capture the world’s attention. But without specific interim goals—and far more precision about what combination prevention and other key concepts mean—the lofty goal of ending the epidemic will not be achieved.

December, 2012
AVAC
AVAC Report

Px Wire is AVAC's quarterly update covering the latest in the field of biomedical HIV prevention research, implementation and advocacy. This issue reviews the research on long-acting injectable antiretrovirals for treatment in HIV-positive people and PrEP in HIV-negative people. This issue also explores progress in implementing oral PrEP in the nearly 24 months since the US Food and Drug Administration approved daily oral TDF/FTC (Truvada) as PrEP.

April, 2014
AVAC
Px Wire

Px Wire is AVAC's quarterly update covering the latest in the field of biomedical HIV prevention research, implementation and advocacy. In this issue of Px Wire, AVAC applauds the nomination of Dr. Debbi Birx as the new US Global AIDS Coordinator. Highlights of this issue also include an examination of why the global systems for tracking voluntary medical male circumcision are lagging behind the actual progress that’s being made—and discusses ways to close this critical data gap.

January, 2014
AVAC
Px Wire

Released at AIDS 2012, this report lays out a plan for beginning to end HIV/AIDS. It includes clear time-bound outcome targets, as well as the responsibilities of different stakeholders to achieve these targets.

July, 2012
amfAR
AVAC
Report/Issue Brief

This annual accounting of funding for biomedical HIV prevention research tracks trends and identifies gaps in investment. The 2013 report finds that the US government was again the biggest contributor and calls for other countries and sectors to step up to end a seven-year trend of flat funding. It also profiles growing interest in research on a therapeutic vaccines.

July, 2013
HIV Vaccines & Microbicides Resource Tracking Working Group
AVAC
International AIDS Vaccine Initiative
UNAIDS
Report/Issue Brief

This annual accounting of funding for biomedical HIV prevention research tracks trends and identifies gaps in investment. The 2012 report finds increased investment by private foundations was unable to make up for the effects of the economic downturn. It also highlights the contributions to prevention research of trial participants.

July, 2012
HIV Vaccines & Microbicides Resource Tracking Working Group
AVAC
International AIDS Vaccine Initiative
UNAIDS
Report/Issue Brief

A comprehensive 2012 report from civil society about the state of voluntary medical male circumcision in Africa. Includes priority recommendations and in-depth discussion of factors influencing national scale-up efforts.  

July, 2012
AVAC
National Empowerment Network of People Living with HIV/AIDS in Kenya
Sonke Gender Justice Network
Uganda Network of AIDS Service Organizations
Report/Issue Brief

The Good Participatory Practice (GPP) guidelines offer trial funders, sponsors, and implementers systematic guidance on how to engage stakeholders throughout the research lifecycle of HIV Prevention Trials. This second edition of the guidelines, published in 2011, contains three sections: The Importance of Good Participatory Practice, Guiding Principles of GPP in Biomedical HIV Prevention Trials, and Good Participatory Practices in Biomedical HIV Prevention Trials.  The sections provide context, foundational principles, and key practices.  

June, 2011
AVAC
UNAIDS
Handbook/Manual
Training Material

The Handbook provides comprehensive introductory material on the key scientific, policy, social, ethical and economic facets of AIDS vaccine research. While the science has changed greatly over the decade since this second edition of the Handbook was published in 2005, the themes and content in many of the essays still hold true. Edited by Patricia Kahn, the handbook contains articles by community educators and advocates, trial staff and volunteers, scientists and researchers, and policy makers and journalists.

May, 2005
AVAC
Edited by Patricia Kahn
Handbook/Manual

Pages